In addition, ALDH1A2, CARD11 and CTLA4 are implicated in cancer immunity and can be useful prognostic biomarkers in some cancer types (Liu et al., 2020; Carter and Pomerantz, 2022; Zhu et al., 2022). Here, CTLA4 is linked to cancer.